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A B S T R A C T
Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:
• To examine the effects of structured psychological interventions, based on cognitive behavioural therapy (CBT) techniques, compared
to all comparators on loneliness in adolescents, adults, and older adults with diagnoses of common mental disorders, or at risk of
loneliness.
• To examine the effects of structured psychological interventions, based on CBT techniques, compared to all comparators on depression
severity, anxiety severity, social connectedness, or quality of life in adolescents, adults, and older adults, with diagnoses of common
mental disorders, or at risk of loneliness.
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B A C K G R O U N D
Description of the condition
Evidence for the harm caused by loneliness is growing. Loneliness
is subjective; it is an emotional response within a person, when
a deficit exists between the desired and actual quantity and
quality of social engagement and relationships (Perlman 1981;
Victor 2005). Social isolation is objective; it is described as having
‘minimal quality of structural (e.g. frequency of social contact) and
functional (e.g. emotional support, or companionship) support’
and can include low density social networks that are not
maintained through frequent engagement (Hayanga 2020; Wang
2017). Loneliness and isolation are different than living alone; it
is possible to experience loneliness or social isolation whilst living
with others (Smith 2019).
Loneliness is found to peak in adolescence and in older people
(Steptoe 2013; Victor 2012). In the UK, over a third of people over
50 years of age report experiencing loneliness (Thomas 2015). One
in five US adults experience loneliness, and there is evidence this is
increasing (Cacioppo 2015). Many other sections of the population
are identified to be at a greater risk of loneliness such as people with
low quality social relationships, people living alone, and recently
bereaved adults (Cohen-Mansfield 2016).
Transient loneliness may be a healthy adaptive behavioural
strategy (Cacioppo 2014; Mann 2017), but long-term loneliness
is associated with psychological changes and poorer health
outcomes (Hawkley 2010; Holwerda 2014; Petitte 2015; Rico-Uribe
2016). Loneliness is a significant public health issue (Gerst-Emerson
2015; Yan 2014), which is associated with mental health problems
(Steptoe 2013), and is linked with increased severity of depression
and anxiety (Lasgaard 2016; Meltzer 2013). The presence of
loneliness is also a risk factor for poor treatment response, and
poorer prognosis among people at risk of, or with established,
depression and anxiety (Wang 2020). Loneliness is associated
with poorer cognitive performance, faster cognitive decline, and
increased negativity and depressed cognition, indicating that
healthy social activity is likely to be integral to cognition in humans
(Cacioppo  2009). There are associations between loneliness and
increased risk of Alzheimer’s disease and cognitive impairment
(Boss 2015; Wilson 2007), eating disorders (Levine 2012), sleep
problems (Smagula 2016), and suicidal ideation and suicide
attempts (Mezuk 2014). Long-term data show that the severity
of loneliness is a predictor for mortality (Steptoe 2013), and is
equivalent to the health risks caused by obesity, smoking, and
physical inactivity (Holt-Lunstad 2015).
Description of the intervention
The evidence on effective interventions to prevent or reduce
loneliness  is largely unclear. Reviews have  identified  four main
intervention strategies to reduce loneliness: i. improving social
skills; ii. enhancing social support; iii. increasing opportunities
for social contact; and iv. modifying  social cognitions (Masi
2011). The Masi 2011 meta-analysis found that the most effective
intervention strategies of the four are cognitive interventions that
seek to change cognition related to social situations.
A review by Mann 2017  summarised the evidence on cognitive
approaches to tackle loneliness, and showed mixed results among
psychological interventions. A trial comparing online cognitive
behaviour therapy (CBT) plus motivational interviewing with online
CBT and brief advice in adolescents with depression, found that
both interventions reduced loneliness at 12 months (Richards
2016). A separate study found that cognitive re-framing did not
reduce loneliness, but the intervention led to greater perceived
control over reducing loneliness (Conoley 1985). A feasibility trial of
a mindfulness intervention found reduced loneliness scores among
Chinese students (Lindsay 2019). The Mann 2017 review highlights
that cognitive changes from loneliness can potentially overlap with
mental processes that contribute to mental health problems; it is
hypothesised that changing a person’s mental processes can lead
to a change in social behaviour, and reduced loneliness over time
(Mann 2017). Brief psychological therapies are advantageous, as
they may be useful for people with chronic loneliness in the context
of social isolation, or with non-clinical populations who are at risk
of developing clinical depression (Gilbody 2017). A recent review
of interventions for social isolation among people experiencing
mental health problems found that the majority of studies had
small sample sizes or did not sufficiently describe allocation
concealment, missing data, and blinding procedures, meaning the
evidence was not sufficient to make clinical recommendations (Ma
2020). However, positive results on loneliness were reported in
two out of six trials that examined interventions with a cognitive
modification component and this led the authors to conclude
that such interventions are ‘promising’. Evidence for the effects of
cognitive interventions on social isolation and other dimensions of
social connectedness is also mixed; one trial of online behavioural
activation versus specialised CBT for mothers with postpartum
depression did not show positive effects on perceived social
support (O'Mahen 2014), and a trial of behavioural activation
for moderate depression among university students found a
moderate, but not statistically significant effect on social support
(Gawrysiak 2009).
This review will focus on trials of first, second, and third wave
CBT interventions. This will include interventions directly targeting
loneliness, or interventions for common mental health problems
for  which loneliness outcomes are reported. First wave CBT
interventions are based on learning (behavioural) theory, and
include classical conditioning and operant conditioning models.
Interventions that use these approaches include exposure-based
treatments for anxiety disorders, and behavioural  treatments for
depression (Abramowitz 2019). Exposure-based treatments involve
coming into contact with a fear-provoking stimulus, and remaining
in contact with it until anxiety reduces (extinction learning).
Behavioural treatments for depression involve monitoring the link
between mood and activity by scheduling activities to assess their
impact on mood, and recording the results in a diary (Martell 2013).
Second wave CBT is based on a standard, Beckian  account of
emotional disorders (Beck 1979). This assumes that previous
experiences lead to the development  of a schema (core beliefs)
that when activated, bias the way information is processed, which
leads to emotional distress. Treatment techniques based on this
approach include Socratic questioning of negative thoughts and
behavioural experiments. In Socratic questioning, the therapist
gently explores how accurate or helpful particularly negative
thoughts are to the person. Outside of sessions, the person is
encouraged to spot and challenge other negative thoughts in a
similar way, oMen using a thought diary. Behavioural experiments
involve doing something (a behaviour) to test the accuracy of a
thought (an experiment, e.g. going to a gathering to test out the
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belief that 'no one will talk to me').  Second wave CBT typically
incorporates techniques from first wave behavioural approaches,
though these are oMen conceptualised from a cognitive, rather than
a behavioural perspective (e.g. keeping a diary of moods, to test the
belief that there is no variation in a person's low mood).
Third wave CBT approaches include a wide range of extensions to
first and second wave CBT. These may be underpinned by cognitive
theory (e.g. the meta-cognitive model) or behavioural theory (e.g.
relational frame theory (Hayes 2004). Unlike second wave CBT,
which focuses on the content of cognition, third wave CBT tends
to place more emphasis on the processes and functions of how we
relate to internal stimuli, such as our thoughts. Treatments typically
classed as third wave CBT include acceptance and commitment
therapy, dialectical behaviour therapy, meta-cognitive therapy,
and mindfulness-based cognitive therapy. Treatment techniques
used in a third wave approach vary substantially, depending on
the particular type of treatment, although they oMen focus on
practising a person's response to internal events (thoughts and
feelings) in a new way (e.g. practising mindfulness, so that thoughts
can be observed rather than getting caught up with them).
Cognitive behavioural therapy for loneliness targets the perceptual
and cognitive biases that result in hypervigilance to negative
social information (Cacioppo 2006; Cacioppo  2009). CBT helps
people to look for disconfirming evidence to re-frame their
perceptions of loneliness and self-efficacy, with the  aim of
changing avoidant behaviours, increasing social connections, and
decreasing loneliness (Kall 2020).  The key techniques include
psychoeducation, social behaviour activation, exposure to social
situations, the challenging of negative automatic thoughts, and
behavioural experiments.
How the intervention might work
While there is substantial evidence that CBT treatments are
effective, there is less consensus about how these treatments
work generally, or specifically, to reduce loneliness. First wave
behavioural explanations draw on classical conditioning models,
such as extinction learning in exposure-based treatments. They
also draw on operant conditioning principles, which argue that
improvements in mental health outcomes occur when there is
a reduction in behaviours that in the short-term are negatively
reinforced, through reducing unpleasant internal states, such as
anxiety, and establishing or re-establishing patterns of behaviour
that in the long-term are linked to improvements in affective
states. As applied to loneliness, these approaches would predict
that encouraging people to engage in patterns of behaviours that
establish or re-establish social interaction, even if this is difficult in
the short-term, may reduce a person's sense of loneliness.
Second wave cognitive approaches suggest that cognitive biases
that contribute to mental health problems could overlap with
those in people experiencing loneliness (Mann 2017); for example,
negative evaluations of other people are associated with both
mental health problems and loneliness (Hawkley 2010). Therefore,
psychological interventions may be able to address mental
processes that are linked with loneliness, and support people to
develop different thinking styles when thinking about themselves
and their relationships. Mann 2017 hypothesise that these changes
can result in changes to social behaviours that subsequently reduce
loneliness.  
Third wave approaches draw on a variety of both cognitive
and behavioural theoretical explanations of emotional change
that expand on, or revise, the first and second wave accounts.
These have not as yet been extensively applied to understanding
loneliness.
Finally, non-specific, or common factor models suggest that change
in CBT and other psychological treatments rests on therapeutic
practices that are common across all psychological treatments,
such as developing a credible treatment rationale, agreement
about the goals of therapy, and establishing an effective working
relationship.
Why it is important to do this review
Large sections of the population have become socially isolated
during the COVID-19 pandemic; either as a public health measure
to prevent the transmission of COVID-19 in the community, or to
protect those who are especially vulnerable. This is of particular
concern for the millions of older adults and adolescents who
are at greater risk of loneliness. Most existing loneliness research
has focused on older adults but  there has been less  exploration
of loneliness in people with, or at risk of developing, mental
health problems, and strategies to tackle the problem. Whilst social
isolation is likely to be a problem for many people, it is not
inevitable that loneliness and mental health problems will follow,
and there is a potential for psychological interventions to be used
as public health measures.
Cultural changes mean that how people socialise is changing;
the effects of this on loneliness are unknown. The UK National
Health Service's (NHS) Five-year forward view for mental health
report states the need to fulfil people’s wishes for good quality
relationships (Mental Health Task Force 2016). There has also been
a UK initiative to understand the social determinants of mental
health problems, and loneliness is becoming an emerging field
of research following recent findings that highlight its potentially
severe health impacts (Royal College of Psychiatrists 2010). There is
an urgent need for evidence to address this problem.
To date, there is no well-developed evidence base supporting the
effects of any intervention on loneliness, but a recent scoping
review reported that psychological interventions have been the
most extensively studied, and have the most robust evidence (Mann
2017). Despite this, evidence for the effectiveness of psychological
interventions that can improve loneliness is mixed, and it is unclear
what forms of therapeutic intervention and what factors, such as
mode of delivery or setting, affect the success of such interventions.
There is a clear need to review the evidence on this subject, but a
Cochrane Review has not yet been conducted. Given the unclear
evidence and a surge in subject interest, it is now timely to review
the evidence, so that public health and clinical practice can be
informed.
O B J E C T I V E S
• To examine the effects of structured psychological
interventions, based on cognitive behavioural therapy (CBT)
techniques, compared to all comparators on loneliness in
adolescents, adults, and older adults with diagnoses of common
mental disorders, or at risk of loneliness.
• To examine the effects of structured psychological
interventions, based on CBT techniques, compared to all
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comparators on depression severity, anxiety severity, social
connectedness, or quality of life in adolescents, adults, and
older adults, with diagnoses of common mental disorders, or at
risk of loneliness.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) will be eligible for inclusion.
We decided to base the review on RCTs because of the robust nature
of the trial design, which reduces bias arising from selection and
allocation of groups. We will also include RCTs that use cluster
allocation, cross-over elements, and trials with any time frame for
outcome follow-up.
We will include studies regardless of their language of publication
and date published. We will include studies regardless of their
publication status, which will encompass unpublished and partially
published studies, and those published in the grey literature.
We will exclude non-randomised studies, e.g. quasi-RCTs, as they
allocate participants to intervention and control groups without
strict randomisation; including these studies could increase the risk
of allocation bias.
Types of participants
Characteristics
We will include studies with participants who are at least 10 years
old. We will define adolescence in line with the World Health
Organization (WHO) definition as those aged 10 to 19 years old
(WHO 2014). We will exclude trials that include participants under
the age of 10. If the age range straddles this cutoff, we will include
the trial if we can establish that > 90% of the sample are older
than 10 years of age. The rationale for selecting this age range is
based on knowledge that loneliness is found to be most prevalent
in adolescence and in older people (Victor 2012). We will not
determine eligibility by any specific demographic features other
than age.
Setting
We will include trials carried out in all settings (primary, secondary,
or community).
Diagnosis
We will include participants with  diagnoses of common
mental health problems,  such as anxiety, depression, obsessive
compulsive disorder, phobias, panic disorders, and post-traumatic
stress disorder. We will also include participants with no clinical
diagnosis of common mental health problems,  but who are
deemed to be at a greater risk of loneliness or social isolation
according to the existing literature. This includes participant
groups, such as new mothers, recently bereaved adults, people
living alone, people with low quality social relationships, and older
adults who are socially isolated (Cohen-Mansfield 2016).
The diagnosis of a common mental health problem must be based
on a structured or semi-structured clinical interview, conducted
to internationally recognised standards (e.g. International
Classification of Diseases, Diagnostic and Statistical Manual of
Mental Disorders), or on a score above a recognised threshold
on a validated depression or anxiety severity measure (e.g.
Patient Health Questionnaire-9 (PHQ-9; Kroenke 2001), Beck
Depression Inventory (BDI; Beck 1961), Generalised Anxiety
Disorder Assessment-7 (GAD-7; Spitzer 2006), or the Beck Anxiety
Inventory (BAI; Beck 1988)). For loneliness, we will include
interventions that focus on preventing loneliness, as well as
reducing pre-existing loneliness (this could be defined using a
recognised loneliness scale, such as the University of California, Los
Angeles (UCLA) loneliness scale (Russell 1978  )). We will exclude
studies that use a single item loneliness scale, or a modified scale
taken from a larger loneliness scale, if the selected components do
not show psychometric properties.
For studies that involve a subset of relevant participants, we
will include the study if 90%  of the participants meet our
eligibility  criteria. To ensure that this does not introduce review
author's biases, we will conduct sensitivity analyses to assess the
affect of the subset of data on the overall outcomes.
We suspect that there will be an insufficient number of studies to
explore differences between studies with special circumstances of
loneliness, such as incarceration or institutionalisation compared
to those who are not. If there are sufficient studies, we will explore
this through meta-regression.
Comorbidities
We will include trials in which participants have concurrent physical
health problems, and those with a clinical diagnosis of mild
to moderate dementia, or cognitive decline.  We  will exclude
trials where participants have a clinical diagnosis of severe and
enduring mental health problems, such as  schizophrenia and
bipolar disorder, severe cognitive decline, or a clinical diagnosis of
a development disability, such as autism spectrum disorder.
Types of interventions
Experimental Intervention
Eligible interventions include first, second, or third wave
cognitive behavioural therapies (CBT) seeking to improve or
prevent  loneliness, as well as other CBT interventions where the
focus is on improving common mental health problems, but in
which loneliness or a related construct is measured as an outcome. 
We will also include trials that examine the effects of a full CBT
intervention combined with other approaches; we will note the
combination treatment in the interpretation of the findings.
Format of psychological therapies
The interventions can differ in terms of the mode of delivery
(e.g. one-to-one, group, face-to-face, bibliotherapy, telephone,
computerised, Internet, blended), the amount of support offered
(e.g. pure self-help, minimal support, at least 20  one-hour
sessions), and the level of training of the person providing the
intervention (e.g. non-therapist technical support, limited training,
fully qualified practitioner). We will include all combinations of
mode, support level, and provider training level.
We will incorporate studies using interventions that are delivered
at varying frequencies, intensity, and time scales. We will include
studies with any length of follow-up.
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There is a risk that including all CBT interventions of varying format,
delivery, and intensity may affect the  intervention effect size.  It
will be important to consider the level of intensity of the therapy
when reviewing the outcomes of the trials.
Comparators
All comparators are eligible for inclusion, including usual care,
waiting-list control, or active comparators. Active comparators
include: pharmacological interventions, non-CBT psychological
interventions, and other CBT interventions (including dismantling
or additive designs involving different combinations of CBT
components in different treatment arms).
We have provided the details of how the different interventions and
comparators will be grouped for analysis in the analysis section,
including pre-planned main comparisons, subgroup analyses, and
sensitivity analyses.
Excluded interventions
We will exclude all trials that do not use CBT (first, second, or third
wave) as the form of intervention. We will not include interventions
that contain only a single CBT component; for example, we would
exclude a non-CBT intervention package that includes social skills
training.
Types of outcome measures
Primary and secondary outcomes are outlined below.
Primary outcomes
• Loneliness, measured by a standard instrument that uses a
validated continuous scale, such as the UCLA Loneliness Scale
(Russell 1978  ) or the De Jong Gierveld Loneliness Scale (De
Jong Gierveld  1985).  We will accept the trial authors' original
definition of loneliness.
Secondary outcomes
• Depression severity, measured by a standard instrument that
uses a validated continuous scale, such as the PHQ-9 (Kroenke
2001), Beck Depression Inventory (Beck 1961), Hamilton
Rating Scale for Depression (Hamilton 1960), Montgomery-
Asberg Depression Rating Scale (Montgomery 1979), or other
standardised depression scales.
• Anxiety severity, measured by a standard instrument that
uses a validated continuous scale, such the Hamilton Anxiety
Sale (Hamilton 1959), Beck Anxiety inventory (Beck 1988),
the trait subscale of the Spielberger State-Trait Anxiety
Inventory (Spielberger 1983),  GAD-7 (Spitzer 2006), or  other
standardised anxiety scales.
• Quality of life, measured by a standard instrument that uses a
validated continuous scale, such as Short Form-36 (Ware 1992),
EuroQol (Brooks 1996), World Health Organization Quality of Life
scales (WHOQOL Group 1998), or other validated measure of
quality of life.
• Social connectedness (e.g. social support, social networks,
and social isolation), measured by a standard instrument that
uses a validated continuous scale, such as the Lubben Social
Network Scale (Lubben 1988), or the Social Provision Scale (SPS;
(Cutrona 1987)).
• Adverse effects, defined by individual studies. We will report the
number and nature of each adverse effect for each study.
Reporting one or more of the secondary outcomes is not an
inclusion criterion for the review. When a published report does
not appear to report one of these outcomes, we will access the
trial protocol and contact the trial authors to ascertain whether
the outcomes were measured but not reported. We will include
relevant trials that measured these outcomes, but did not report
the data at all, or not in a usable format, as part of the narrative.
Search methods for identification of studies
Electronic searches
An information specialist with the Cochrane Common Mental
Disorders (CCMD) Group will search the following bibliographic
databases, using relevant subject headings, keywords, and search
syntax appropriate to each resource.
• Cochrane Common Mental Disorders Controlled Trials Register
(CCMDCTR; all available years; Appendix 1);
• Cochrane Central Register of Controlled Trials (CENTRAL;
current issue, in the Cochrane Library);
• MEDLINE Ovid (1946 onwards);
• Embase Ovid (1974 onwards);
• PsycINFO Ovid (all years; Appendix 2);
• Web of Science Social Science Citation Index (SSCI; all years);
• Social Care Online (www.scie-socialcareonline.org.uk; all years).
We will search ClinicalTrials.gov and the World Health Organization
(WHO) International Clinical Trials Registry Platform (ICTRP; all
years) to identify ongoing or unpublished trials.
We will not apply any restriction on date, language, or publication
status to the searches.
Searching other resources
Grey literature
We will search the following sources of grey literature (primarily for
dissertations and theses):
• Open Grey (www.opengrey.eu/);
• ProQuest Dissertations & Theses Global (www.proquest.com/
products-services/pqdtglobal.html);
• DART-Europe E-theses Portal (www.dart-europe.eu/);
• EThOS – the British Libraries e-theses online service
(ethos.bl.uk/);
• Networked Digital Library of Theses and Dissertations (NDLTD;
search.ndltd.org);
• Open Acces Theses and Dissertations (oatd.org).
Reference lists
We will check the reference lists of all relevant study reports and
reviews retrieved by the searches. We will also conduct a forward
citation search on the Web of Science and Google Scholar, to
identify additional research.
Personal communication
We will contact trial authors and subject experts for information on
unpublished or ongoing studies, or to request additional data.
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Data collection and analysis
Selection of studies
Two review authors (PH, EE) will independently screen titles and
abstracts of all the potential studies we identify as a result of
the search, and code them as 'retrieve' (eligible or potentially
eligible or unclear) or 'do not retrieve', using Covidence soMware
(Covidence). If there are any disagreements, a third review author
will be asked to arbitrate (DM). We will retrieve the full-text study
reports or publication of those coded 'retrieve'; two review authors
(PH, EE) will independently screen the full-text, identify studies
for inclusion, and identify and record reasons for exclusion of
the ineligible studies. We will resolve any disagreement through
discussion, or if required, we will consult a third person (DM). We
will identify and exclude duplicates and collate multiple reports
of the same study, so that each study, rather than each report,
is the unit of interest in the review. We will record the selection
process in sufficient detail to complete a PRISMA flow diagram and
'Characteristics of excluded studies' table (Liberati 2009). When
the full text is not available we will first contact the trial author.
If we receive no response, we will contact the British Library to
gain access, or purchase the study via the University of York where
possible.
Data extraction and management
We will use a data collection form for study characteristics and
outcome data, which has been piloted on at least one study
in the review. Two review authors (PH, EE) will independently
extract study characteristics from included studies. We will
extract the following study characteristics into Covidence soMware
(Covidence).
• Methods: study design, total duration of study, number of study
centres and location, study setting, and date of study
• Participants: total randomised, number lost to follow-up or
withdrawn, number analysed, mean age, age range, gender,
severity of condition, medications taken, diagnostic criteria,
inclusion criteria, and exclusion criteria
• Interventions: intervention, comparison, mode of delivery,
frequency, length of sessions, treatment duration, level of
support provided by treatment providers, level of training of
treatment providers
• Outcomes: we will collect outcomes of loneliness, depression
severity, anxiety severity, quality of life, social support, social
networks and social isolation, and report the time points
• Notes: funding for trial, notable conflicts of interest of trial
authors, and adverse events
Two review authors (PH, EE) will independently extract outcome
data from included studies. We will resolve disagreements by
consensus, or by involving a third review author (DM). One review
author (EE) will import data from Covidence into the Review
Manager 5 file (Covidence; Review Manager 2014). We will double
check that data are entered correctly by comparing the data
presented in the Review Manager 5 file with the data extraction
form.
Main comparisons
• CBT versus the control condition
• CBT versus other active psychological treatments
• CBT versus active pharmacological treatment
Assessment of risk of bias in included studies
Two review authors (PH, EE) will independently assess risk of bias
for each study using version 2 of the Cochrane 'Risk of bias' (RoB
2) tool (Sterne 2019), outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2019b). We will assess
the risk of bias of the results for a specific outcome in each trial
according to the following domains:
1. Bias arising from the randomisation process; randomisation and
allocation
2. Bias due to deviations from intended interventions (assignment
to intervention);
3. Bias due to missing outcome data;
4. Bias in the measurement of the outcome;
5. Bias in the selection of the reported result.
We will assess the risk of bias for the outcomes of the included
trials that will be included in our 'Summary of findings' table.
We will  quantify  the effect of assignment to the interventions at
baseline, regardless of whether the interventions are received as
intended (the intention-to-treat effect; (Higgins 2019b)).
We will use the signalling questions in the 'RoB 2' tool, and rate each
domain as low risk of bias, some concerns, or high risk of bias. We
will summarise the risk of bias judgements across different studies
for each of the domains listed for each outcome. The overall risk
of bias for the result is the least favourable assessment across the
domains of bias. When considering treatment effects, we will take
into account the risk of bias for the studies that contribute to that
outcome.
Cross-over and cluster-randomised control trials bias (including the
five RoB 2 categories mentioned previously) will be analysed using
a more suited method that focusses on common biases produced
from these trial formats. We will analyse cluster-randomised trials
for bias that arises from the randomisation process, baseline
imbalances, missing outcome data, measurement of the outcome,
selection of the reported result, and loss of cluster (Higgins
2020a). We will analyse cross-over trials for bias that arises from
the randomisation process, carry-over effects, missing outcome
data, measurement, and selection of the reported results (Higgins
2020a).
Where inadequate details are provided in the original report, we
will contact corresponding trial authors to provide clarification.
Disagreements will be resolved following discussions with DM.
Measures of treatment effect
We will manipulate data presented as a scale so that there is a
consistent direction of effect. We will narratively describe skewed
data, reported as medians and interquartile ranges.
Dichotomous data
We will analyse dichotomous outcomes by calculating a pooled risk
ratio (RR) and 95% confidence intervals (95% CIs).
A score over one suggests a benefit. We will analyse dichotomous
data using an odds ratio measurement. We will then convert these
odds ratios into risk ratios to allow easier interpretation, using
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the formula described in the Cochrane Handbook for Systematic
Reviews of Interventions (Schünemann 2020b). For measures that
use a cutoff score to determine dichotomous data, we will report
the cutoff score used in each study, and address differences in
sensitivity in the narrative synthesis.
We will also calculate the risk difference (RD), which in turn, can
be used to calculate the number needed to treat for an additional
beneficial outcome (NNTB), which is another way to analyse  the
outcome effect. The NNTB is defined as the expected number
of people needed to receive the intervention compared to the
comparator group for one additional person to either avoid or
achieve an outcome in given time scale (Schünemann 2020a)
Continuous data
If all the studies for a particular outcome of interest use the same
standardised measure, we will report a mean difference (MD) with
95% CI.
If the trials use different instrument to measure the  outcome,
we will calculate a standardised mean difference (SMD) with
95% CI. The standardised mean difference measures the size of
the intervention effect of each study compared to the between-
participant variability in outcome measurements recorded in
each individual study (Schünemann  2020b). To allow for easier
interpretation and analysis of the results,  we will convert    the
SMD into the specific clinical measures used in the studies (such
as the  UCLA Loneliness Scale (Russell 1978  ), or the De Jong
Gierveld Loneliness Scale (De Jong Gierveld  1985), as this is a
more familiar unit of measurement. This is done by multiplying
the SMD by an estimate of the standard deviation (SD) associated
with the outcome measure instrument, according to the Handbook
(Schünemann 2020b).
Management of time points
We plan to categorise the post-intervention outcomes into short-
term outcomes (< 6 months, including end of treatment time
points), medium-term (6 to 12 months), and long-term outcomes
(≥12 months). If a study reports follow-up outcomes at more than
one time point within one of these time frames, we will select the
outcome reported at the latest point within the time frame.
Hierarchy of outcomes
We will separately analyse symptom severity (e.g. depression
or anxiety severity typically using continuous measures)  and
diagnostic outcomes (typically assessed using dichotomous
outcomes), and will consider symptom severity as having priority
over diagnostic outcomes. If a trial reports the use of more than
one instrument assessing for each outcome, we will prioritise in
the following order: clinician-rated scale, informant-rated scale,
and self-rated scale.  If multiple outcome measures are used of
the same type (e.g. two self-report measures), we will choose the
outcome measure that is most frequently used across studies.
If multiple outcome measures of the same type have equivalent
availability across studies, we will choose the one with the
strongest psychometric evidence in previous research.
Unit of analysis issues
Cross-over trials
We will include trials that use a cross-over element, using only data
extracted from the first trial period. Our decision to only include
the first phase was based on the risk of 'carry over' effects (when
the effects of the previous intervention continue to have an effect
in the subsequent trial phase) and 'period' effects (changing of
the underlying condition systematically or background factors alter
which can oMen arise from cross-over trials; (Higgins 2020a)).
Cluster-randomised trials
We will include trials that use cluster-randomisation. In order
to include cluster-randomised trials correctly,  we will follow the
advice given in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2020a).
Trials with multiple treatment groups
Studies that include multiple-arms run the risk of introducing a
unit-of-analysis error if the data are not managed appropriately. To
combat this issue, we will take the following approach:
• If trials include multiple relevant treatment groups, we will
combine relevant intervention groups and useful  comparator
groups (into active or control) in a pair-wise comparison;
• If trials include multiple active comparator groups, we will
combine these  to compare one active group with the
intervention group;
• If trials include multiple usual care, placebo, or waiting-list
comparator groups, we will combine these to compare one non-
active group with the intervention group;
• If trials include multiple relevant interventions with a single
control group, we will divide the control group in pair-wise
comparisons.
Dealing with missing data
We will contact investigators or study sponsors in order to verify key
study characteristics and obtain missing numerical outcome data
when needed, and when possible (e.g. when a study is identified as
abstract only).
When standard deviations (SDs) are missing, we will attempt to
obtain these data by contacting trial authors. When SDs are not
available from trial authors, we will calculate them from P values,
t-values, CIs, or standard errors, if these are reported in the articles
(Deeks 1997).
If a vast majority of SDs are available, and only a minority of SDs
are unavailable or unobtainable, we will use the method devised by
Furukawa and colleagues to impute SDs and calculate percentage
responders (da Costa 2012; Furukawa 2005, Furukawa 2006). If
we use this method, we will interpret data with caution, and will
take into account the degree of observed heterogeneity. We will
also undertake a sensitivity analysis to examine the effect of the
decision to use imputed data.
If additional figures are not available or obtainable, and it is not
deemed appropriate to use the Furukawa method as described
above, we will not include the trial data in the comparison of
interest.
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Where there are missing data in included studies, we will include
available case data (i.e. where data from only participants with a
final assessment were included), or where trial authors imputed
missing data, using techniques, such as multiple imputation, mixed
model regression, or last observation carried forward (LOCF).
Assessment of heterogeneity
We will inspect forest plots visually to consider the direction
and magnitude of effects and the degree of overlap between
confidence intervals. We will use the Chi2 test to assess statistical
heterogeneity, and this will provide evidence of variation in effect
estimates beyond that of chance. The Chi2 test has low power
to assess heterogeneity when a low number of participants or
trial are included, so we will conservatively set the P value at
0.1 (Deeks 2020). We will also quantify heterogeneity using the I2
statistic, giving us values that calculate the percentage of variability
attributed to heterogeneity rather than to chance (Deeks 2020).
We will consider I2 values in the range of 50% to 90% to represent
substantial statistical heterogeneity, and we will explore such cases
further.
The magnitude and direction of treatment effects will affect the
importance of the observed I2 statistic. The forest plots will provide
an estimate of the Tau2 between-trial variance in a random-effects
meta-analysis (Deeks 2020). We will use the Tau2 estimate to
determine an approximate range of intervention effects for the
primary outcome; this will indicate the true spread of the effects of
the intervention (Deeks 2020).
Assessment of reporting biases
To minimise the risk of reporting bias, we will conduct
extensive searches to include a range of English and non-English
published trials, unpublished trials, clinical study reports, and trial
registries data in the review. By doing this, it will minimise the risk
of bias due to missing results.
We will also attempt to identify outcome reporting bias in trials by
recording all relevant trial outcomes, planned and reported, and
noting where outcomes are missing. If we find evidence of missing
outcomes, we will attempt to obtain any available data by directly
contacting the trial authors.
If we are able to pool more than 10 trials, we will create and
examine a funnel plot to explore possible small study biases for
the primary outcomes. We will construct a funnel plot of effect size
versus inverse variance to test for publication bias. An asymmetrical
funnel plot is strongly indicative of publication bias, and means that
the results of the meta-analysis should be interpreted with caution
(Egger 1997).
Data synthesis
We will initially group studies and report by: time frame (short-,
medium-, and long-term), comparator conditions (active versus
control, and active versus active), and participant age category
(adolescent, adult, or older adult). We will use the WHO's
definitions of adolescence (aged 10 to 19 years; (WHO 2014)), and
older adults (aged over 60 years; (WHO 2001)). We will consider
adults as aged 18 years and over.
We will undertake meta-analyses only where this is meaningful, i.e.
if the treatments, participants, and the underlying clinical question
are similar enough for pooling to make sense.
We will use a random-effects model in the analyses, as we
predict a high rate of heterogeneity between the selected studies.
A random-effects meta-analysis model suggests that the effects
being estimated in different studies follow some sort of distribution
(Deeks 2020).
Narrative synthesis
If we carry out a narrative synthesis, we will develop a theory of how
the intervention might work, according to the included studies.
Then, we will conduct a preliminary synthesis by systematically and
thoroughly assessing each study to extract relevant information, in
order to evaluate the similarities and differences between them.
With this information, we will look closely at the relationships of the
data within and between studies. Finally, we will assess how robust
our synthesis has been, by looking at the methods used to complete
the synthesis, and the quality of the data produced.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses, if there are
sufficient studies to do so:
• Delivery of the therapy: we will categorise the interventions
depending on their mode of delivery. This will allow us to
compare the difference between interventions delivered face-
to-face versus those delivered via remote means (telephone,
web based).
• Therapy support: we will categorise therapies depending on
the level of support provided, such as supported versus
unsupported. We predict that there will be a positive association
between the level of support provided and the effectiveness of
the therapy.
• Type of psychological therapy: we will categorise  the
form of psychological therapy, where  possible, into generic
psychological therapies versus therapy that focuses on targeting
loneliness. We anticipate that interventions that directly target
loneliness could have a greater positive effect on the outcomes.
• Diagnostic equivalence: we will categorise the diagnostic
method, based on the tool used, for studies that include a
measure of mental health, for example studies which use a
screening tool (e.g. PHQ9) versus a diagnostic method (e.g.
meeting the DSM or ICD criteria for a mental disorder). This will
allow us to assess if effectiveness estimates differ in studies that
include participants with a common mental disorder, based on
a rating scale or a diagnostic tool.
• Type of therapy: we will categorise interventions based on
whether first, second, or third wave techniques were used to
compare differences between these types.
We will explore the relationship between effect size and
methodological features identified in the 'Risk of bias' assessment
using a meta-regression. If there are not sufficient studies to
conduct a statistical analysis, we will address this in the narrative
synthesis.
We will use the formal test for subgroup differences in Review
Manager 5, and base our interpretation on this (Review Manager
2014).
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Sensitivity analysis
We plan to carry out the following sensitivity analyses, to test
whether key methodological factors or decisions affected the main
result:
• Trial quality: we will exclude trials that are at greater risk of bias
(lower quality). We will define quality using domains of the 'Risk
of bias 2' tool, including allocation concealment and attrition
rate.  If there are differences in risk of bias between domains,
then the rating indicating the higher risk of bias will be used.
• Multi-component or complex therapy: we will exclude multi-
component or complex therapies. This will show the effect of the
additional components in the therapies, compared with generic
CBT alone.
Reaching conclusions
We will base our conclusions only on findings from the quantitative
or narrative synthesis of studies included in this review.We will
avoid making recommendations for practice; our implications for
research will suggest priorities for future research, and outline the
remaining uncertainties in the area.
Summary of findings and assessment of the certainty of the
evidence
We will create a 'Summary of findings' table using the following
outcomes:
• Loneliness
• Depression severity
• Anxiety severity
• Quality of life
• Social connectedness, i.e. social support, social networks, and
social isolation
• Adverse events
We will use the five GRADE considerations (study limitations,
consistency of effect, imprecision, indirectness, and publication
bias) to assess the quality of the body of evidence as
it relates to the studies that contribute data to the
meta-analyses for the prespecified outcomes. We will use
methods and recommendations described in Chapter 14 of
the Cochrane Handbook for Systematic Reviews of Interventions
(Schünemann  2020a), and GRADEpro soMware (GRADEpro GDT).
We will create a separate 'Summary of findings' table for each
comparison (CBT versus the control condition,  and CBT versus
other active psychological treatments). We will justify all decisions
to downgrade the quality of the evidence using footnotes, and
we will make comments to aid the reader's understanding of the
review, where necessary. We will downgrade by one level for each
GRADE factor, up to a maximum of three levels for all factors. If there
are very severe problems for a single factor, we will downgrade by
two levels.
Examples of each factor for which we would downgrade the level of
the evidence:
• study limitations: selective outcome reporting, or recruitment
bias in cluster-randomised trials
• consistency of effect: unexplained heterogeneity of results
• imprecision: the presence of wide confidence intervals
• indirectness: time differences in measurement of outcomes
• publication bias: over-estimation of underlying beneficial
effects due to publication selection bias
Two review authors (PH, EE), working independently, will make
judgements about the quality of the evidence, with disagreements
resolved by discussion, or involving a third review author (DM).
Judgements will be justified, documented, and incorporated into
the reporting of results for each outcome. The 'Summary of
findings' table will be completed before writing the discussion,
conclusions, and abstract, to highlight any potential influence the
study quality had on the reported outcomes.
We will use these domains to rate the overall quality of evidence for
the outcomes according to the following categories:
• High  quality: further research is very unlikely to change our
confidence in the estimate of effect;
• Moderate quality: further research is likely to have an important
impact on our confidence in the estimate of effect, and may
change the estimate;
• Low quality: further research is very likely to have an important
impact on our confidence in the estimate of effect, and is likely
to change the estimate;
• Very low quality: we are very uncertain about the estimate.
We will report other key information in the 'Summary of findings'
table, such as study sample size and data collection time frame.
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A P P E N D I C E S
Appendix 1. Cochrane Specialized Register
Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR)
The Cochrane Common Mental Disorders Group (CCMD) maintains an archived controlled trials register known as the CCMDCTR. This
specialized register contains over 40,000 reference records (reports of RCTs) for anxiety disorders, depression, bipolar disorder, eating
disorders, self-harm, and other mental disorders within the scope of this Group. The CCMDCTR is a partially studies-based register, with
more than 50% of reference records tagged to around 12,500 individually PICO-coded study records. Reports of studies in the register were
collated from (weekly) generic searches of key bibliographic databases to June 2016, which included: MEDLINE (1950 onwards), Embase
(1974 onwards), PsycINFO (1967 onwards), quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL), and review-
specific searches of additional databases. Reports of studies were also sourced from international trials registries, drug companies, the
handsearching of key journals, conference proceedings and other (non-Cochrane) systematic reviews and meta-analyses. Details of CCMD's
core search strategies (used to identify RCTs) are on the Group's website, with an example of the core MEDLINE search displayed below.
[MeSH Headings]: eating disorders/ or anorexia nervosa/ or binge-eating disorder/ or bulimia nervosa/ or female athlete triad syndrome/
or pica/ or hyperphagia/ or bulimia/ or self-injurious behavior/ or self mutilation/ or suicide/ or suicidal ideation/ or suicide, attempted/
or mood disorders/ or affective disorders, psychotic/ or bipolar disorder/ or cyclothymic disorder/ or depressive disorder/ or depression,
postpartum/ or depressive disorder, major/ or depressive disorder, treatment-resistant/ or dysthymic disorder/ or seasonal affective
disorder/ or neurotic disorders/ or depression/ or adjustment disorders/ or exp antidepressive agents/ or anxiety disorders/ or
agoraphobia/ or neurocirculatory asthenia/ or obsessive-compulsive disorder/ or obsessive hoarding/ or panic disorder/ or phobic
disorders/ or stress disorders, traumatic/ or combat disorders/ or stress disorders, post-traumatic/ or stress disorders, traumatic, acute/
or anxiety/ or anxiety, castration/ or koro/ or anxiety, separation/ or panic/ or exp anti-anxiety agents/ or somatoform disorders/ or body
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dysmorphic disorders/ or conversion disorder/ or hypochondriasis/ or neurasthenia/ or hysteria/ or munchausen syndrome by proxy/ or
munchausen syndrome/ or fatigue syndrome, chronic/ or obsessive behavior/ or compulsive behavior/ or behavior, addictive/ or impulse
control disorders/ or firesetting behavior/ or gambling/ or trichotillomania/ or stress, psychological/ or burnout, professional/ or sexual
dysfunctions, psychological/ or vaginismus/ or Anhedonia/ or Affective Symptoms/ or *Mental Disorders/ OR [Title/ Author Keywords]:
(eating disorder* or anorexia nervosa or bulimi* or binge eat* or (self adj (injur* or mutilat*)) or suicide* or suicidal or parasuicid* or
mood disorder* or affective disorder* or bipolar i or bipolar ii or (bipolar and (affective or disorder*)) or mania or manic or cyclothymic* or
depression or depressive or dysthymi* or neurotic or neurosis or adjustment disorder* or antidepress* or anxiety disorder* or agoraphobia
or obsess* or compulsi* or panic or phobi* or ptsd or posttrauma* or post trauma* or combat or somatoform or somati#ation or medical*
unexplained or body dysmorphi* or conversion disorder or hypochondria* or neurastheni* or hysteria or munchausen or chronic fatigue*
or gambling or trichotillomania or vaginismus or anhedoni* or affective symptoms or mental disorder* or mental health).tw,kf. AND [RCT
filter]: (controlled clinical trial.pt. or randomised controlled trial.pt. or (randomi#ed or randomi#ation).ab,ti. or randomly.ab. or (random*
adj3 (administ* or allocat* or assign* or class* or control* or determine* or divide* or distribut* or expose* or fashion or number* or place*
or recruit* or subsitut* or treat*)).ab. or placebo*.ab,ti. or drug therapy.fs. or trial.ab,ti. or groups.ab. or (control* adj3 (trial* or study or
studies)).ab,ti. or ((singl* or doubl* or tripl* or trebl*) adj3 (blind* or mask* or dummy*)).mp. or clinical trial, phase ii/ or clinical trial, phase
iii/ or clinical trial, phase iv/ or randomised controlled trial/ or pragmatic clinical trial/ or (quasi adj (experimental or random*)).ti,ab. or
((waitlist* or wait* list* or treatment as usual or TAU) adj3 (control or group)).ab.)
Records were screened for reports of RCTs within the scope of the Cochrane Common Mental Disorders Group. Secondary reports of RCTs
were tagged to the appropriate study record.
The rationale of maintaining a comprehensive specialised register was reviewed when the editorial group moved from the University of
Bristol to the University of York in June 2016. At this time, the Group decided to archive the CCMDCTR and return to searching the medical
and psychological literature directly, on a review-by-review basis.
*****************************************************************************************************************************
For this review, the information specialist with CCMD will initially cross-search the CCMDCTR-Studies and References register (all years to
June 2016) using the following terms:
#1 ("social isolation" or loneliness or abandonment or alienation or "separation reactions" or (separation adj1 anxiety) or homesickness
or quarantine or lockdown or "lock down" ):eh,emt,ky,mc,mh
#2 (lonely or loneliness or ((social* or societal*) adj (confine* or isolat* or inclusion or participation))):ti,ab
#3 "sense of belonging":ti,ab
#4 (homesick* or "home sick*"):ti,ab
#5 (anxiety adj1 separation):ti,ab
#6 (quarantine* or lockdown* or "lock down*"):ti,ab
#7 ((social* adj3 (contact* or connect* or integrat* or isolat* or network* or provision* or relationship* or support*) adj3 (scale* or subscale*
or score* or test* or measure* or questionnaire* or index or indices or inventory or interview* or survey* or form or checklist or "check
list*")) or ("mental health continuum" adj2 (SF or "short form")) or MHC-SF) [all fields]
#8 (#1 or #2 or #3 or #4 or #5 or #6 or #7)
Key to search fields.
ab: abstract; eh,emt: EMTREE headings; ky: Cochrane Review Group (CRG) keywords; mc: MeSH checkwords; mh: MeSH headings; ti:title.
Appendix 2. PsycINFO Ovid search
Further searches will be conducted directly on the main bibliographic databases, with an example of the PsycINFO search displayed below.
Ovid APA PsycInfo database <1806 to current>
Search Strategy:
--------------------------------------------------------------------------------
1. social isolation/ or loneliness/ or abandonment/ or alienation/
2. (loneliness or ((social* or societal*) adj (confine* or isolat* or inclusion or participation))).ti,ab,id.
3. "sense of belonging".ti,ab,id.
4. homesickness/
5. (homesick* or home sick*).ti,ab,id.
6. separation reactions/ or exp separation anxiety/
7. (anxiety adj1 separation).ti,ab,id.
8. (quarantine? or lockdown? or lock down?).ti,ab,id.
9. or/1-8
10. (loneliness scale? or social network scale? or social provision scale?).af.
11. (loneliness or lonely or (social* adj (contact? or connect* or isolat* or network?))).tm.
12. (((mental health continuum) adj2 (short form or SF)) or MHC-SF).af.
13. or/10-12
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14. cognitive behavior therapy/ or cognitive restructuring/ or cognitive techniques/ or cognitive therapy/ or dialectical behavior therapy/
or schema therapy/ or problem solving/
15. psychotherapy/ or exp group psychotherapy/ or counseling/ or group counseling/ or exp psychotherapeutic counseling/ or
psychotherapeutic techniques/
16. mindfulness-based interventions/ or mindfulness/ or "acceptance and commitment therapy"/
17. relaxation therapy/ or progressive relaxation therapy/ or autogenic training/ or guided imagery/ or meditation/
18. ((cogniti* or behavio*) adj3 (counsel* or intervention or therap* or psychotherap* or training or treatment or technique* or restructur*
or defusion)).ti,ab,id.
19. (CBT* or CBASP or contingency management or covert conditioning or covert sensiti#ation or defusion or MBCT* or problem focus* or
rational emotive or REBT or schema).ti,ab,id.
20. ((problem* adj2 (focus* or sol*)) or role play* or schema* or self-control* or self control*).ti,ab,id,hw.
21. (((psychotherap* or therap*) adj3 (commitment or acceptance)) or (self* adj (control or analysis or direct* or esteem or help or instruct*
or manage*))).ti,ab,id.
22. ((attribution* or reattribution*) adj3 (therap* or psychotherap*)).ti,ab,id.
23. (metacognitive or meta-cognitive or mindfulness* or third wave or (behavio* adj3 modification) or (thought* adj3 suppress*) or
rumination).ti,ab,id.
24. (exposure therapy or exposure task* or psychoeducat* or psycho-educat* or relaxation or sensitivity training or assertiveness training
or self talk or (social adj2 (coach* or skill* or effectiveness))).ti,ab,id,hw.
25. exp behavior therapy/ or exp behavior modification/ or behavior change/ or behavior contracting/
26. behavioral activation system/
27. ((behavio* adj1 activ*) or BATD).ti,ab,id.
28. (behavio* adj3 (reinforce* or re-inforce*)).ti,ab,id.
29. (behavio* adj2 (change or contracting or modification or modify*)).ti,ab,id.
30. ((activit* or event?) adj2 (schedul* or training)).ti,ab,id.
31. planned behavior/
32. ((pleas* or enjoyable or rewarding) adj (activit* or event?)).ti,ab,id.
33. exp operant conditioning/
34. (operant conditioning or instrumental learning).ti,ab,id.
35. exp contingency management/
36. (positive interaction* or avoidant coping or environmental contingenc* or contigency management).ti,ab,id.
37. functional analysis.ti,ab,id,sh.
38. (behavio* and (self adj (care or efficacy or evaluat* or monitor*))).ti,id,hw.
39. (behavio* adj (counsel* or intervention or train* or treatment? or therap* or psychotherap*)).ti.
40. (((contingent or positive) adj1 reinforc*) or (reinforc* adj3 (environment* or experience*))).ti,ab,id.
41. intervention/ or group intervention/ or group discussion/
42. (group adj2 (program* or rehabilitation)).ti,ab,id.
43. or/14-42
44. clinical trials.sh.
45. (randomi#ed or randomi#ation or randomi#ing).ti,ab,id.
46. (RCT or at random or (random* adj3 (administ* or allocat* or assign* or class* or control* or crossover or cross-over or determine* or
divide* or division or distribut* or expose* or fashion or number* or place* or recruit* or split or subsitut* or treat*))).ti,ab,id.
47. (control* and (trial or study or group) and (placebo or waitlist* or wait* list* or ((treatment or care) adj2 usual))).ti,ab,id,hw.
48. ((single or double or triple or treble) adj2 (blind* or mask* or dummy)).ti,ab,id.
49. trial.ti.
50. placebo.ti,ab,id,hw.
51. treatment outcome.md.
52. treatment effectiveness evaluation.sh.
53. mental health program evaluation.sh.
54. or/44-53
55. (9 and 43 and 54)
56. (13 and 43 and 54)
57. (55 or 56)
Key to search fields.
af: all fields; ab: abstract; id: key concepts; hw: subject heading word; md: methodology; sh: subject heading; ti: title, tm: tests & measures.
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